A View LCS vs eMurmur Heart AI
AI Verdict
Choose AVIEW LCS if…
Choose A View LCS if your primary need is a comprehensive, AI-powered radiological analysis of thoracic CT scans. This tool is ideal for lung cancer screening programs, enabling automated nodule detection, emphysema quantification, and coronary artery calcification scoring from a single low-dose CT, streamlining multi-disease assessment. It's best suited for radiology departments and pulmonology clinics requiring detailed imaging insights and automated reporting.
View AVIEW LCS →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you require an AI-driven solution for automated auscultation analysis of heart and lung sounds. This platform is excellent for initial screening, remote monitoring, and telehealth consultations, providing immediate insights into murmurs and hemodynamic status without requiring advanced imaging. It's particularly useful for primary care, internal medicine, and cardiology practices seeking a non-invasive, accessible tool for early detection and ongoing assessment.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Pricing | Subscription or one-off payment | Contact for quote |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Web-based, Mobile App, API integration |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers mobile app and web portal access, along with hardware-neutral compatibility and telehealth features, making it highly accessible and flexible for various clinical settings and users. A View LCS, while providing comprehensive reporting, appears more specialized in its interface and use case.
Clinical Value
AVIEW LCSBoth tools are FDA-cleared and offer significant clinical value in their respective domains. A View LCS provides comprehensive diagnostic insights for multiple critical thoracic conditions (lung cancer, emphysema, coronary artery disease) from a single low-dose CT scan, offering a broader diagnostic scope from one input. eMurmur Heart AI focuses on automated auscultation analysis for heart and lung sounds.
Pricing & Value
TieNeither tool provides transparent pricing information, both requiring direct contact for quotes. Without specific pricing details or publicly available value propositions beyond their features, it is impossible to compare their pricing and value effectively.
Enterprise Readiness
AVIEW LCSBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong enterprise readiness. A View LCS, however, provides more diverse deployment options including cloud, hybrid, local hardware, and virtualized solutions, which can cater to a wider range of enterprise IT infrastructures and data governance requirements.
Innovation
eMurmur Heart AIBoth tools are innovative in their respective fields. eMurmur Heart AI stands out with its application of AI to auscultation, combined with hardware neutrality and seamless integration for telehealth and remote monitoring, significantly enhancing accessibility and care delivery models. A View LCS's comprehensive multi-disease analysis and CT kernel conversion technology are also innovative in radiology.
Support & Docs
TieWhile both companies appear to offer some level of documentation and contact points, neither the provided facts nor web searches yielded specific details on dedicated support channels, service level agreements, or comprehensive documentation portals to differentiate them effectively. Coreline Soft mentions 'PDF Catalogs | Technical Documentation' and eMurmur mentions 'FAQs' and 'Contact us' on their website, but a direct comparison of their support infrastructure is not possible with the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW LCS | eMurmur Heart AI |
|---|---|---|
| Product Name | A View LCS | eMurmur Heart AI |
| Company | Coreline Soft Co. | CSD Labs |
| Primary Application Area | Comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. | Automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. |
| Core AI Functionality | Automated lung nodule detection and classification, Emphysema analysis and quantification (LAA), Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass) | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs |
| Reporting & Output | Automated comprehensive report generation (PDF, DICOM PDF, SR), CT kernel conversion AI technology | Mobile app (iOS, Android) and web portal for access, Live streaming and remote auscultation for telehealth, Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring |
| Supported Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring AVIEW LCS and eMurmur Heart AI.